截止2020年08月11日21時(shí)58分Cardiovascular Systems（CSII）最新價(jià)31.1600，漲跌額0.1900，漲跌幅0.61%，昨收30.9700，今開(kāi)31.2700，最高31.2700，最低31.0900，成交量6417手。

　　Cardiovascular Systems（CSII）主要指標(biāo)（幣種：美元）：截止2020年03月31日Cardiovascular Systems（CSII）市盈率（TTM）-126.578646118291，市凈率（MRQ）9.37210305847349，每股收益（TTM）-0.272162809892955，每股凈資產(chǎn)3.67580251572811，每股股息（USD）--，周息率--%，收入總額1.94億，收入總額同比7.90731047985627%，歸母凈利潤(rùn)-1207.00萬(wàn)，歸母凈利潤(rùn)同比-600.116009280742%，毛利率80.0952582229805%，凈利率-6.22168155505956%，總股本3895.10萬(wàn)，總市值（USD）13.42億。

　　Cardiovascular Systems（CSII）2019年07月01日至2020年03月31日United States金額（USD）1.86億，比率95.68%。

　　公司介紹： Cardiovascular Systems, Inc., based in St. Paul, Minn., is a medical device company focused on developing and commercializing innovative solutions for treating vascular and coronary disease. The company’s Orbital Atherectomy Systems treat calcified and fibrotic plaque in arterial vessels throughout the leg and heart in a few minutes of treatment time, and address many of the limitations associated with existing surgical, catheter and pharmacological treatment alternatives. The U.S. FDA granted the first 510(k) clearance for the use of the Orbital Atherectomy System in peripheral arteries in August 2007.

　　本站數(shù)據(jù)均為參考數(shù)據(jù)，不具備市場(chǎng)交易依據(jù)。